ABSTRACT. Osteopontin (OPN) plays an important role in the metastasis and recurrence of tumors after resection of hepatocellular carcinoma (HCC). In this study, the down-regulation effect on OPN expression in HCC cells of RNA interference (RNAi) molecules designed to target different segments of OPN was investigated to identify a more effective site for OPN knockdown. Specific small interfering RNAs (siRNAs A, B, and C) of OPN were synthesized and transfected into an HCC cell line (HEP-G2; representing the OPNi-A, OPNi-B, and OPNi-C groups). Fluorescent quantitative polymerase chain reaction and immunohistochemical methods were used to detect the mRNA and protein expression of OPN before and after RNAi. Results showed that after transfection, the fluorescence intensity of the OPNi-A group was greater than those of the OPNi-B and OPNi-C groups. After 48 h of transfection, the ΔCT values of OPN mRNA expression in the OPNi- A-C groups increased from 8.31 ± 1.58, 8.78 ± 1.49, and 8.25 ± 1.51 to 12.14 ± 1.43, 10.22 ± 1.97, and 10.48 ± 1.88, respectively (P < 0.05), and the OPN protein levels (immunohistochemistry scores) decreased from 6.44 ± 1.67, 5.43 ± 2.05, and 5.45 ± 2.52 to 2.84 ± 1.52, 4.43 ± 1.65, and 3.95 ± 1.43 points, respectively. These results indicated that RNAi based on different segments of the OPN gene had different downregulatory effects on OPN expression. Synthesis of targeted siRNA aimed at specific OPN segments might have important significance for dealing with the invasiveness and metastasis of HCC cells.
INTRODUCTION
Osteopontin (OPN) plays an important role in metastasis and recurrence of tumors after resection of hepatocellular carcinoma (HCC) Tang et al., 2004; Bhattacharya et al., 2012) . Most previous studies have examined the function of OPN (Chen et al., 2010; Lin et al., 2011; Liu et al., 2011) . It has been found that OPN might be the molecular marker of hepatic metastasis as well as an important feedback factor of hepatic carcinoma. Angiogenesis is the foundation of malignant tumor invasion and metastasis. OPN exerts important functions in inducing angiogenesis in neurofibromatosis, multiple myeloma, and lung cancers during their invasion and metastasis processes. Although OPN promotion of tumor invasion and metastasis is not yet proven, the inter-reaction process between OPN and tumor metastasis-associated factors is still being researched and the status of OPN in the processes of malignant tumor formation, and especially of hepatic carcinoma invasion and metastasis, is as of yet undiscovered. OPN might take the role of ''molecular engine'' in these processes. Thus, the OPN gene sequence might be considered a key target for research, based upon its potential function in hepatic carcinoma invasion and metastasis. We think that, as there are protein domains of OPN, its segments might play key roles in its function. In this study, the effect of RNA interference on expressions of different OPN fragments in HCC was investigated. The objective of the study was to seek the most effective sequence for siRNA-mediated OPN knockdown, to provide a specific tool for use in the clinical therapy of HCC.
MATERIAL AND METHODS
Determination and synthesis of OPN-specific siRNA sequences OPN was provided by Sigma Aldrich (St. Louis, MO, USA). With the assistance of PubMed (National Center for Biotechnology Information), the OPN mRNA sequence (NM 001040060.1) was retrieved, and three pairs of siRNA sequences were designed. The design principles were as follows: 1) the length of the siRNA was approximately 21-23 bp, with 2-3 nt at the 3'-end; 2) the target sequence was located at a site after 70-100 bp from the initiator ATG codon; 3) both initiator codons should be AA; 4) siRNAs were chosen with the lowest GC content (40-55%); 5) the primary structural region of the mRNA was avoided; 6) the uniqueness of the sequence was confirmed by BLAST homology comparison. The names and sequences of the OPN siRNAs are shown in Table 1 . 
Quantitative fluorescent polymerase chain reaction (PCR)
After 24, 36, and 48 h, total RNA was extracted from the cells, and quantitative fluorescent PCR was performed. The PCR amplification procedure was as follows: Stage 1 (predenaturation): 95°C for 30 s (1 cycle); Stage 2 (PCR): 95°C for 5 s, 60°C for 34 s (40 cycles); Stage 3 (dissociation): 95°C for 15 s, 60°C for 1 s, and 95°C for 15 s (1 cycle). The detection and analysis of RNA expression was as follows: 1.5 g agarose (Sigma-Aldrich Corp.) was added to 100 mL Tris-acetate-EDTA buffer (Nanjing MeiBo Biological Technology Co., Ltd., Nanjing, China) to prepare a 1.5% agarose gel. A 10-mL PCR product aliquot was added to 2 mL sample buffer, and the mixture was added to a well of the agarose gel. At the same time, the DNA marker (Shanghai Sangon Biological Engineering Technology & Services Co., Ltd., Shanghai, China) was added to a separate well on the agarose gel. Electrophoresis was performed at 80 V for 30-45 min. The agarose gel was placed in an ImageMaster VDS system (GE Healthcare Life Sciences, Piscataway, NJ, USA). The DNA bands were scanned and the integral optical density (IOD) value was analyzed. The IOD ratio of the target gene to the internal reference (GAPDH, Shanghai Sangon Biological Engineering Technology & Services Co., Ltd.,) reflected the relative expression amount of the target gene.The OPN mRNA expression was estimated using 2 -ΔΔCt method (Livak and Schmittgen, 2001 ).
Immunohistochemistry
Cells transfected with siRNA (OPNi-A, OPNi-B, and OPNi-C; 21, 21, and 16 samples in each group, respectively) were fixed with 4% polyformaldehyde for 40 min, and the sections were prepared. The sections were washed with phosphate-buffered saline (PBS), and then were treated with 0.3% Triton X-100/PBS. The specific mouse anti-human monoclonal OPN antibody (dilution 1:300; Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA) was dropped on each section, followed by overnight incubation at 4°C. After three washes using PBS of 3 min each, the secondary antibody Envision TM reagent (Envision Solar International Inc., San Diego, CA, USA) was dropped onto each section. The DAB staining was performed. The degree of coloring of each tissue section was observed under a microscope. The OPN antibody-positive paratonsillar cortex specimen was used as a positive control, and PBS instead of primary antibody was used as negative control.
Determination of results
Results were scored as 0-3 using a composite score method. The scoring according to coloring depth of the mucus in the cytoplasm or glandular cavity was as follows: light brown, 1; brown, 2; dark brown, 3; no coloration, 0. The scoring according to positive cell proportion was as follows: <30%, 1; 30-70%, 2; >70%, 3; no coloration, 0. The integration of above two scores was divided into 4 grades: score of 0, negative (-); 2-3, weak positive (+); 4, positive (++); 5-6, strong positive (+++). A score of over 4 represented over-expression.
Statistical analysis
Data are reported as means ± standard deviation. Statistical analysis was performed using the SPSS 13.0 statistical software (SPSS, Chicago, IL, USA). A t-test was used to analyze the differences among the three groups, and P < 0.05 was considered as statistically significant.
RESULTS

siRNA transfection efficiency
After 8 h from transfection of the siRNA A fragment into HEP-G2 cells, the green fluorescence of cells could be observed under an inverted microscope. The fluorescence intensity of the cells transfected with the A fragment was greater than those from the B and C fragments, respectively (Figures 1-3) . 
Expression of OPN mRNA
Expression of OPN mRNA was represented by ΔCT (threshold cycle: the number of cycle of fluorescent signal reaching set threshold in each reaction tube). Results showed that there was a linear relationship between the initial copy number of each template and the template CT value. The larger the initial copy number, the smaller the CT value, and vice versa. Meanwhile, in order to observe the effect over time, the OPN RNA was collected at 24, 48, and 72 h after transfection, and the inhibition rate was detected. Results showed that 48 h after transfection, the ΔCT values of OPN mRNA expression in the OPNi-A, OPNi-B, and OPNi-C groups increased from 8.31 ± 1.58, 8.78 ± 1.49, and 8.25 ± 1.51 to 12.14 ± 1.43, 10.22 ± 1.97, and 10.48 ± 1.88, respectively (P < 0.05). These results suggested that the inhibitory rate of siRNA A on OPN mRNA expression was the strongest (Table 2) . 
Expression of the OPN protein
As shown in Table 3 , the immunohistochemistry scores of OPN protein expression in OPNi-A, OPNi-B, and OPNi-C groups were 2.84 ± 1.52, 4.43 ± 1.65 and 3.95 ± 1.43 points, respectively. The protein expression level in the OPNi-A group was significantly lower than those in the OPNi-B and OPNi-C groups (P < 0.05). 
DISCUSSION
In this study, siRNAs against three segments of OPN were designed, and were transfected into HEP-G2 cells using Lipofectamine™ 2000. From the results, we found that the experimental data matched our expectations. The inhibitory rate of siRNA A on OPN expression was found to be stronger than siRNAs A and B. Segment A might represent a region of the mRNA more accessible to the siRNA; however, the exact mechanism of action still requires elucidation. If, through knockdown analysis, we can discover the nature of OPN function, which might be to serve as a trigger for metastasis and the recurrence of HCC (Wai and Kuo, 2008; Chen et al., 2011) , this might contribute to better progress in the development of effective treatments for HCC.
Some researchers Tang et al., 2004) have used genome and transcriptome technology to study the molecular genetic characteristics and gene expression profiles of surgical specimens from patients with HCC, metastatic human HCC xenografts in nude mice, and cell models and mechanisms of liver metastasis. After 10 years of concerted efforts, these studies have demonstrated that liver cancer metastasis-related gene changes already exist at the primary tumor stage. This has provided a new methodology for early diagnosis, treatment, and non-surgical intervention of HCC. It has also been confirmed that OPN is a key HCC metastasis-associated factor (Takafuji et al., 2007) and has a significant predictive value. This demonstration obtained the second prize in China's State Natural Science Award (the highest award in the medical field) in 2010, highlighting the importance of this finding.
siRNA molecules are short segments of double-stranded RNA (dsRNA) that can lock onto the complementary homologous mRNA sequences as their target goal and degrade them (Gotoh et al., 2002; Pan et al., 2007) . The basic mechanism of RNAi is that dsRNA enters cells and is sheared by intracellular dicer RNAse III and other dsRNA binding factors into 21-23 nt siRNAs. The siRNAs combine with certain proteins and enzymes PAZ proteins, and DNA and RNA helicases) to form the RNA-induced silencing complex (RISC). Under the guidance of RNAi, RISC finds and identifies the complementary mRNA, and then the reverse strand of the siRNA combines with the helical structure of the RNA complex and the target mRNA, and shears the target mRNA. Thereby, the expression of the target gene is blocked, leading to gene silencing. RISC can also participate in another RNAi cycle . In this, RISC is positioned by base pairing to homologous mRNA transcripts, so that target gene transcription is blocked, generating the corresponding loss of functional phenotype. Therefore, this process has also been called posttranscriptional gene silencing Celetti et al., 2005) . RNAi technology has been widely applied to various fields in the life sciences, and is a revolutionary scientific development. In our previous studies (Seidman, 2002; de Silva Rudland et al., 2006) , the structure and function of OPN have been studied in-depth. The results from those studies demonstrated that the molecular weight of OPN is small, but due to the complexity of the siRNA process, the synthesis of siRNA drugs for OPN has been very difficult with a high failure rate.
Therefore, we segmented the OPN nucleotide sequence and analyzed its more effective fragments, in order to synthesize more effective targeted siRNA molecules. The preexamination of the RNA sequence can save more time and cost. In this paper, the siRNA molecules targeted to different OPN fragments were transfected into HEP-G2 cells, and the mRNA and protein levels of OPN were measured. These experiments demonstrated that all three fragments were able to down-regulate the expression of OPN, but fragment A led to the most obvious decreases. Therefore, siRNA A had the strongest effect, whereas siRNAs B and C were relatively weak. This might be related to specific sites in the sequence of siRNA A might have more sensitive reaction sites. In addition, the preferential effect might occur in conjunction with other factors involved in the modification process of OPN gene transcription and translation (Wai and Kuo, 2004; Robison and Lake, 2005; Teramoto et al., 2005) . With a better understanding of the OPN molecular structure, the discovery of new tumor metastasisassociated factors related to OPN and of small molecule drugs for OPN might provide a turning point for the development of an effective gene therapy of HCC.
